PetMed Express (NASDAQ: PETS)
PetMed Express Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
PetMed Express Company Info
PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Delray Beach, FL.
News & Analysis
Why PetMed Express Was a Dog of a Stock This Week
Its quarterly results included a surprise net loss.
This Under-the-Radar E-Commerce Stock Is Aiming to Expand Its Market
The online pet pharmacy is in the early stages of expanding its sights, making it an interesting buy for risk-tolerant investors.
Is PetMed's 4.3% Yield Safe?
The company's latest earnings numbers suggest the dividend could be in trouble.
Pet Stocks Have Gone to the Dogs This Earnings Season
Freshpet is the latest pet industry stock to fall short of Wall Street expectations. Who let the dogs out?
PetMed Express Earnings: Its Bite Is Worse Than Its Bark
Another miss for the pet wellness stock finds it scrambling for a new growth driver.
Why PetMed Express Stock Is Sinking Today
An analyst's downgrade zapped some of Wednesday's momentum.
Why Petmed Express Stock Skyrocketed Today
A surge in meme stocks and a short squeeze sent the online pet pharmacy soaring.
What's Behind PetMed Express' Disappointing Q4 Results
The reopening of veterinary clinics and pet retailers caused lower sales for the online pet pharmacy.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.